|
|
|
| 1 |
8,436,168 |
Methods of making HIV attachment inhibitor prodrug compound and
intermediates
|
| 2 |
8,436,158 |
Antibodies to IL-6 and their uses
|
| 3 |
8,436,000 |
Substituted carbamate derivatives as modulators of corticotropin-releasing
factor receptor activity
|
| 4 |
RE44,186 |
Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV
and method
|
| 5 |
8,431,568 |
Aromatic heterocyclic fused indolobenzadiazepine HCV NS5B inhibitors
|
| 6 |
8,426,414 |
Modulators of G protein-coupled receptor 88
|
| 7 |
8,425,904 |
Human antibodies that bind mesothelin, and uses thereof
|
| 8 |
8,420,830 |
Macrocyclic factor VIIa inhibitors useful as anticoagulants
|
| 9 |
8,420,811 |
Tetrahydroisoquinolines and intermediates therefor
|
| 10 |
8,420,365 |
11.beta.hydroxysteroid dehydrogenase type 1
|
| 11 |
8,420,098 |
Fibronectin based scaffold domain proteins that bind to PCSK9
|
| 12 |
8,415,386 |
Azolopyrrolone melanin concentrating hormone receptor-1 antagonists
|
| 13 |
8,415,374 |
Combinations of hepatitis C virus inhibitors
|
| 14 |
8,415,367 |
Pyrimidinylpiperidinyloxypyridinone analogues as GPR119 modulators
|
| 15 |
8,415,340 |
Triazine kinase inhibitors
|
| 16 |
8,410,155 |
Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea
analogs as factor XIA inhibitors
|
| 17 |
8,410,139 |
Prodrugs of a piperidinyl derivative as modulators of chemokine receptor
activity
|
| 18 |
8,410,128 |
Triazolopyridine compounds useful as kinase inhibitors
|
| 19 |
8,404,896 |
N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP
inhibitors for the treatment of atherosclerosis and cardiovascular
diseases
|
| 20 |
8,404,741 |
Glycine chroman-6-sulfonamides for use as inhibitors of diacylglycerol
lipase
|
| 21 |
8,404,689 |
Heterocyclic amide compounds useful as kinase inhibitors
|
| 22 |
8,399,647 |
Alpha5-beta1 antibodies and their uses
|
| 23 |
8,399,623 |
Human antibodies that bind mesothelin, and uses thereof
|
| 24 |
8,399,451 |
Heterocyclic compounds
|
| 25 |
8,394,968 |
Hepatitis C virus inhibitors
|
| 26 |
8,394,823 |
Triazolopyridine compounds useful as DGAT1 inhibitors
|
| 27 |
8,389,527 |
Substituted imidazopyridazines useful as kinase inhibitors
|
| 28 |
8,389,509 |
Substituted pyrazole compounds
|
| 29 |
8,383,812 |
N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-A][1,-
3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual
modulator of chemokine receptor activity, crystalline forms and processes
|
| 30 |
8,383,779 |
Human antibodies that bind mesothelin, and uses thereof
|
| 31 |
8,383,639 |
HIV integrase inhibitors
|
| 32 |
8,383,094 |
Hepatitis C virus inhibitors
|
| 33 |
8,377,980 |
Hepatitis C virus inhibitors
|
| 34 |
8,372,847 |
Pyrazinone modulator of corticotropin-releasing factor receptor activity
|
| 35 |
8,372,837 |
Pyridone and pyridazone analogues as GPR119 modulators
|
| 36 |
8,367,709 |
Dipeptide analogs as coagulation factor inhibitors
|
| 37 |
8,362,065 |
Carbazole carboxamide compounds useful as kinase inhibitors
|
| 38 |
8,362,020 |
Hepatitis C virus inhibitors
|
| 39 |
8,362,004 |
Piperazine analogs as broad-spectrum influenza antivirals
|
| 40 |
8,357,809 |
Acyclic I.sub.Kur inhibitors
|
| 41 |
8,357,806 |
Process for synthesizing substituted isoquinolines
|
| 42 |
8,357,704 |
Fused heterocyclic compounds as inhibitors of potassium channel function
|
| 43 |
8,354,548 |
Glycine chroman-6-sulfonamides for use as inhibitors of diacylglycerol
lipase
|
| 44 |
8,354,513 |
Polynucleotides encoding BSL2vcvc-lg
|
| 45 |
8,354,432 |
Cyclic derivatives as modulators of chemokine receptor activity
|
| 46 |
8,354,398 |
Substituted isoxazole compounds
|
| 47 |
8,354,264 |
Polynucleotides encoding novel PCSK9 variants
|
| 48 |
8,350,084 |
Alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid
peptide production
|
| 49 |
8,349,880 |
Bicyclic compounds for the reduction of beta-amyloid production
|
| 50 |
8,344,160 |
Pyrrolone melanin concentrating hormone receptor-1 antagonists
|
